Cargando…
Mesenchymal Stem/Stromal Cell Production Compliant with Good Manufacturing Practice: Comparison between Bone Marrow, the Gold Standard Adult Source, and Wharton’s Jelly, an Extraembryonic Source
Many clinical trials report mesenchymal stem/stromal cells (MSCs) efficacy in various indications. Therefore, standardization of MSC production becomes necessary. MSC properties are impacted by tissue origin, especially if they are from extraembryonic tissue or adult sources. For this reason, we eva...
Autores principales: | Laroye, Caroline, Gauthier, Mélanie, Antonot, Hélène, Decot, Véronique, Reppel, Loïc, Bensoussan, Danièle |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6947040/ https://www.ncbi.nlm.nih.gov/pubmed/31847319 http://dx.doi.org/10.3390/jcm8122207 |
Ejemplares similares
-
Wharton’s jelly‐derived stromal cells and their cell therapy applications in allogeneic haematopoietic stem cell transplantation
por: Pochon, Cécile, et al.
Publicado: (2022) -
Bone marrow vs Wharton’s jelly mesenchymal stem cells in experimental sepsis: a comparative study
por: Laroye, Caroline, et al.
Publicado: (2019) -
Efficacy of Wharton Jelly Mesenchymal Stromal Cells infusions in moderate to severe SARS-Cov-2 related acute respiratory distress syndrome: a phase 2a double-blind randomized controlled trial
por: Pochon, Cécile, et al.
Publicado: (2023) -
Are the Immune Properties of Mesenchymal Stem Cells from Wharton’s Jelly Maintained during Chondrogenic Differentiation?
por: Voisin, Charlotte, et al.
Publicado: (2020) -
Chondrogenic induction of mesenchymal stromal/stem cells from Wharton’s jelly embedded in alginate hydrogel and without added growth factor: an alternative stem cell source for cartilage tissue engineering
por: Reppel, Loïc, et al.
Publicado: (2015)